Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure

Journal of the American College of Cardiology

Volumn 13, Issue 7, 1989, Pages 1534-1539

  Gottlieb, Stephen S ^a   Kukin, Marrick L ^a   Ahern, Deborah ^a   Packer, Milton ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR;

ADULT; AGED; FOLLOW UP; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; NORADRENALIN BLOOD LEVEL; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL NATRIURETIC FACTOR; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMAN; MALE; MIDDLE AGE; MONITORING, PHYSIOLOGIC; PROGNOSIS; RISK FACTORS; STROKE VOLUME; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS;

EID: 0024381672     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(89)90344-6     Document Type: Article

References (38)

1. Activity of the sympathetic nervous system and the renin-angiotensin system assessed by plasma hormone levels and their relationship to hemodynamic abnormalities in congestive heart failure
2. Plasma norepinephrine in congestive heart failure
3. Spontaneous hereditary myocardial degeneration and congestive heart failure in a strain of Syrian hamsters
4. Role of neurohormonal mechanisms in determining survival in patients with severe chronic heart failure
5. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure
6. Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure
7. Plasma levels of immunoreactive atrial natriuretic factor in healthy subjects and in patients with edema
8. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure
9. Prostaglandins in severe heart failure: relation to activation of the renin-angiotensin system and hyponatremia
10. Atrial natriuretic peptide elevation in congestive heart failure in the human
11. Role of atrial natriuretic peptide in adaptation of sodium excretion with reduced renal mass
12. Hemodynamic changes mimicking a vasodilator drug response in the absence of drug therapy after right heart catherization in patients with chronic heart failure
13. Nonparametric estimation from incomplete observations
14. Evaluation of survival data and two new rank order statistics arising in its consideration
15. Covariance analysis of censored survival data
16. Role of atrial peptides in body fluid homeostasis
17. Atrial natriuretic factor in normal subjects and heart failure patients: plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion
18. Human atrial natriuretic peptide: plasma levels, hemodynamic, hormonal, and renal effects in patients with severe congestive heart failure
19. Atrial natriuretic factor inhibits norepinephrine release evoked by sympathetic nervous stimulation in isolated perfused rat mesenteric arteries
20. Interactions of atrial natriuretic peptide with the sympathetic and endocrine systems in the pithed rat
21. Effect of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the reninaldosterone axis in dogs
22. Antidiuretic hormone and atrial natriuretic peptide in congestive heart failure
23. Plasma atrial natriuretic pepetide level as an index for the severity of congestive heart failure
24. Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity
25. Effects of enalapril on mortality in severe congestive heart failure results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
26. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration cooperative study
27. Plasma α natriuretic peptide in cardiac impairment
28. Factors influencing the one-year mortality of dilated cardiomyopathy
29. Correlation of left ventricular ejection fraction and plasma atrial natriuretic peptide in congestive heart failure (letter)
30. Atrial natriuretic factor secretion in dogs with experimental high-output heart failure
31. Reflex suppression of renin secretion during distension of cardiopulmonary receptors in dogs
32. Renal effects of left atrial distension in dogs with chronic congestive heart failure
33. Relation of arrhythmias and electrolyte abnormalities to survival in patients with severe chronic heart failure
34. Monophasic action potentials at discontinuation of cardiopulmonary bypass: evidence for contraction-excitation feedback in man
35. Effects of noradrenalin and isoprenaline in combination with alpha- and beta-receptor blocking substances, on the action potential of cardiac Purkinje fibres
36. Effects of the renin-angiotensin system on sustained ventricular tachycardia after myocardial infarction (abstr)
37. Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy
38. Enalapril for congestive heart failure (letter)